Anne Samuel
Stock Analyst at JP Morgan
(3.40)
# 963
Out of 4,714 analysts
58
Total ratings
52.63%
Success rate
3.86%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Neutral | $208 → $218 | $213.03 | +2.33% | 5 | Dec 16, 2024 | |
| PGNY Progyny | Downgrades: Neutral | $22 → $17 | $17.60 | -3.41% | 6 | Dec 2, 2024 | |
| EVH Evolent Health | Maintains: Overweight | $45 → $15 | $11.88 | +26.26% | 10 | Nov 22, 2024 | |
| DOCS Doximity | Maintains: Neutral | $30 → $48 | $55.22 | -13.07% | 5 | Nov 21, 2024 | |
| OMCL Omnicell | Maintains: Neutral | $37 → $44 | $45.32 | -2.91% | 4 | Nov 21, 2024 | |
| IQV IQVIA Holdings | Maintains: Overweight | $279 → $240 | $197.39 | +21.59% | 5 | Nov 5, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $26.20 | +6.87% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $21.55 | -11.83% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $24.63 | -14.74% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $7.42 | +75.20% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $36.98 | -26.99% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $4.36 | +14.68% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $97.47 | +10.80% | 8 | Apr 2, 2024 |
Veeva Systems
Dec 16, 2024
Maintains: Neutral
Price Target: $208 → $218
Current: $213.03
Upside: +2.33%
Progyny
Dec 2, 2024
Downgrades: Neutral
Price Target: $22 → $17
Current: $17.60
Upside: -3.41%
Evolent Health
Nov 22, 2024
Maintains: Overweight
Price Target: $45 → $15
Current: $11.88
Upside: +26.26%
Doximity
Nov 21, 2024
Maintains: Neutral
Price Target: $30 → $48
Current: $55.22
Upside: -13.07%
Omnicell
Nov 21, 2024
Maintains: Neutral
Price Target: $37 → $44
Current: $45.32
Upside: -2.91%
IQVIA Holdings
Nov 5, 2024
Maintains: Overweight
Price Target: $279 → $240
Current: $197.39
Upside: +21.59%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $26.20
Upside: +6.87%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $21.55
Upside: -11.83%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $24.63
Upside: -14.74%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $7.42
Upside: +75.20%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $36.98
Upside: -26.99%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $4.36
Upside: +14.68%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $97.47
Upside: +10.80%